Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
4 studies found for:    19898183 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting Eplerenone for Central Serous Chorioretinopathy
Condition: Central Serous Chorioretinopathy
Intervention: Drug: Eplerenone 50mg
2 Completed
Has Results
Topical Interferon Gamma-1b for Central Serous Chorioretinopathy
Conditions: Retinal Disease;   Macular Disease
Intervention: Drug: Interferon gamma-1b
3 Completed Choroidal Thickness Measurements During Central Serous Chorioretinopathy (CSCR) Treatment
Condition: Choroidal Thickness
Intervention:
4 Recruiting Short-Term Oral Mifepristone for Central Serous Chorioretinopathy
Condition: Central Serous Chorioretinopathy
Interventions: Drug: Mifepristone;   Drug: Placebo

Indicates status has not been verified in more than two years